Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS

AUCKLAND, New Zealand, Nov. 29, 2022 /PRNewswire/ -- Today New Zealand based soft-tissue regeneration company Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions, the Company has entered FY23 with momentum and delivere...

2022-11-29 13:24 2061

Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline

Acquisition accelerates Full-Life's transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform BRUSSELS and WATCHUNG, N.J. and SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- Full-Life Technologies, a fully integrated global r...

2022-11-29 10:00 2345

Cambridge Cognition and Luca Healthcare Announce a Strategic Partnership and an Exclusive Licensing Agreement to Commercialize Cambridge Cognition's Suite of Cognitive Assessment Tools and Brain Health Products for the China Market

SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- Cambridge Cognition, a leading technology company, which develops and markets digital solutions to assess brain health, and Luca Healthcare,China's category leader in developing and commercializing clinically validated digital health solutions, today annou...

2022-11-29 10:00 2168

Comirnaty Bivalent Vaccine Arrives in Hong Kong SAR and Macau SAR and Will Soon Be Available to the Local Residents

SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- On November 26, 2022, Shanghai Fosun Pharma (Group) Co., Ltd.("Fosun Pharma", Stock Code: 600196.SH; 02196.HK) announced that the first batch of about 770,000 doses of the Comirnaty Original/Omicron BA.4/BA.5 bivalent vaccine (i.e. Comirnaty Original/Omicro...

2022-11-28 22:59 3825

Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan

NEW TAIPEI CITY, Taiwan, Nov. 28, 2022 /PRNewswire/ -- Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three premier medical device manufacturing companies to form an integrated full function service group. The newly formed Medeologix family of companies, with a ...

2022-11-28 21:00 3901

SeekIn Receives CE-IVD Mark Approval for SeekInCure® Cancer Recurrence Monitoring Kit

First-of-its-kind blood-based pan-cancer recurrence monitoring test SHENZHEN, China, Nov. 28, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for SeekInCure® Cancer Recurrence Moni...

2022-11-28 21:00 3398

DetectedX Introduces ImageDx to Transform Image-Based Education at RSNA

Showcases Momentum with New Customers, New Subscriber Options and the Addition ofProfessor László Tabár to the Executive Team CHICAGO, Nov. 28, 2022 /PRNewswire/ -- Building on the successful U.S. launch at the SBI/ACR Breast Imaging Symposium, DetectedX, the leaders in intelligent interactive ...

2022-11-28 21:00 2886

GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)

SHANGHAI and NEW ORLEANS, Nov. 28, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the preliminary safety and efficacy data from the Phase I study of GFH009 monotherapy for treatment ...

2022-11-28 19:00 2532

Lyvgen Announces Phase 2 Clinical Collaboration with Bristol Myers Squibb to Evaluate LVGN7409 in Combination with Nivolumab in Non-Small Cell Lung Cancer Patients

* LVGN7409 is a next generation CD40 agonistic antibody; Nivolumab is a PD-1 checkpoint inhibitor; docetaxel is an anti-tubulin chemotherapy agent * Combination study to begin in 1st half 2023 SHANGHAI and SUZHOU, China, Nov. 27, 2022 /PRNewswire/ -- Lyvgen Biopharma, a leading innovative glob...

2022-11-28 07:00 1925

VUNO Showcases their AI Solutions and Research Results at RSNA 2022

SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- VUNO Inc., a leading South Korean artificial intelligence (AI) developer, announced that it will participate in the Radiological Society ofNorth America 2022 (RSNA 2022). This year, VUNO will focus on highlighting how their breakthrough AI technol...

2022-11-25 23:00 12222

VUNO Showcases their AI Solutions and Research Results at RSNA 2022

New study on deep learning technology for improving MRI image quality published in European Radiology

SwiftMR™, an AI-powered MRI reconstruction solution from AIRS Medical proved its performance for enhancing the image quality of 3D high-resolution MRI SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- A recent study published in European Radiology

2022-11-25 23:00 12580

Neurophet, to participate in the Radiological Society of North America RSNA 2022

̵ Introducing 4 products at the booth including the main product Neurophet AQUA ̵ Conducting in-depth discussions jointly team members from R&D and cooperation with several global companies SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution comp...

2022-11-25 22:00 12196

Neurophet, to participate in the Radiological Society of North America RSNA 2022

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

* Polytaxel, a novel pain-free anticancer drug, may not require break periods * A new standard of care, more convenient than docetaxel, is suggested * Hyundai Bioscience to enter clinical trial on pancreatic cancer in Australia * Patient-centered chemotherapy to enable outpatients to live nor...

2022-11-25 21:00 12194

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Concord Medical Schedules 2022 Annual Meeting of Shareholders

BEIJING, Nov. 25, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensi...

2022-11-25 19:30 11713

Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System

SUZHOU, China, Nov. 25, 2022 /PRNewswire/ -- inQB8 Medical Technologies, LLC (inQB8), in Partnership with Peijia Medical Limited (Peijia, (9996.HK)), announced today that it has successfully implanted the MonarQ Transcatheter Tricuspid Valve in a 75-year-old female suffering from severe torrentia...

2022-11-25 16:00 2344

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

- Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) ofAustralia for the indication of glabellar lines - First shipment and local launch planned for Q1 2023...Plans to cooperate with major chain clinics and key opinion leaders SEOUL, South Korea,...

2022-11-24 22:00 4928

Edenlux launches AI-based service "Otus Plus Eye Health Care Report"

SEOUL, South Korea, Nov. 24, 2022 /PRNewswire/ -- On November 24, Edenlux (CEO Sy Park) announced that it will provide an artificial intelligence (AI) eye health management report for the users of Otus Plus, its flagship product.

2022-11-24 22:00 4226

Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND

SHANGHAI, Nov. 24, 2022 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its clinical trial application for 9MW3011 Injection used in patients with polycythemia vera was formally approved by the United States Food...

2022-11-24 21:00 4142

Rokid and Eyedaptic Launch EYE5 to Help AMD Patients Enhance Their Vision

HANGZHOU, China, Nov. 23, 2022 /PRNewswire/ -- Recently, Rokid, an augmented reality glasses manufacturer, partnered with Eyedaptic to unveil the all-new EYE5 smart glasses at the American Academy of Optometry 2022 Annual Meeting and Expo. The latest model brings wearability to a whole new level...

2022-11-24 12:20 2340

Korea Ginseng Corp.: As an adaptogenic herb, Korean red ginseng boosts the human immune response

* KORESELECT Immune receives the 2022 Taste For Life Immunity Essential award CERRITOS, Calif., Nov. 23, 2022 /PRNewswire/ -- Korean Ginseng Corp., the world's number one Korean red ginseng brand, is highlighting Korean red ginseng as another way to stay healthy.

2022-11-23 23:00 3436

Korea Ginseng Corp.: As an adaptogenic herb, Korean red ginseng boosts the human immune response

1 ... 88 89 909192 93 94 ... 255